PROFUND ADVISORS LLC

Position in SANA — Sana Biotechnology, Inc.

CIK 1129919 BETHESDA, MD

Position in SANA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$347,261

-$105,250 QoQ

Shares Held

99,502

-36.7% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#70

of 211 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. SANA ranks #121 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$347,261	99,502	-36.7%	Shares	Sole	2026-08-11
2026-03-31	$452,511	157,122	+54.0%	Shares	Sole	2026-04-27
2025-12-31	$415,327	102,046	+76.8%	Shares	Sole	2026-02-06
2025-09-30	$204,906	57,720	+40.5%	Shares	Sole	2025-11-06
2025-03-31	$69,017	41,082	-32.2%	Shares	Sole	2025-05-08
2024-12-31	$98,738	60,576	-5.6%	Shares	Sole	2025-02-14
2024-09-30	$266,868	64,151	+1.7%	Shares	Sole	2024-11-14
2024-06-30	$344,433	63,083	-18.3%	Shares	Sole	2024-08-13
2024-03-31	$772,020	77,202	+9.2%	Shares	Sole	2024-05-08
2023-12-31	$288,468	70,703	+27.8%	Shares	Sole	2024-02-14
2023-09-30	$214,065	55,314	-10.0%	Shares	Sole	2023-11-13
2023-06-30	$366,402	61,477	-19.0%	Shares	Sole	2023-08-10
2023-03-31	$248,333	75,943	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.